Moderna Omicron Booster Going to Clinic in Weeks: CEO

The transcript discusses the current and future strategies for COVID-19 vaccines, focusing on the Omicron variant and potential future variants. It highlights the importance of vaccination and booster shots, the transition from pandemic to endemic, and the development of combined flu and COVID vaccines. The debate on vaccine mandates and their impact on transmission is also covered, along with Moderna's market position and future prospects.

What are the implications of vaccine mandates in relation to transmission?

What is the expected timeline for the combination flu and COVID vaccine?

What factors contribute to the waning efficacy of vaccines over time?

How does the current public perception of Moderna's vaccine impact its market performance?